Génome Québec — Commercialization Priming

The Génome Québec Commercialization Priming program is primarily open to the following individuals and groups:1. Principal Investigators (PI): - Faculty members at McGill University holding the role of Assistant Professor, Associate Professor, or Full Professor. - Eligible to hold Tri-Agency research funding.2. Co-Investigators (Co-I): - Faculty members at McGill University with positions as Assistant Professor, Associate Professor, or Full Professor. - Researchers from D2R’s partner institutions, including McMaster University, the University of British Columbia, the University of Ottawa, and Université de Sherbrooke, who are on the approved list by partners. - Eligible to hold Tri-Agency research funding.3. Collaborators: - Individuals from McGill, other academic institutions, industry, government, or community organizations who contribute meaningfully to the project. - Not eligible to receive funding from D2R.4. Partner Organizations: - Organizations such as government entities, industries, associations, non-profit organizations, or other institutions contributing or committing cash or in-kind support for the proposed research.However, the program does not explicitly specify eligibility criteria for particular company types or industry sectors other than those collaborators and partner organizations may represent.